These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19641107)

  • 1. Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome.
    Wirth EK; Roth S; Blechschmidt C; Hölter SM; Becker L; Racz I; Zimmer A; Klopstock T; Gailus-Durner V; Fuchs H; Wurst W; Naumann T; Bräuer A; de Angelis MH; Köhrle J; Grüters A; Schweizer U
    J Neurosci; 2009 Jul; 29(30):9439-49. PubMed ID: 19641107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells.
    Braun D; Kinne A; Bräuer AU; Sapin R; Klein MO; Köhrle J; Wirth EK; Schweizer U
    Glia; 2011 Mar; 59(3):463-71. PubMed ID: 21264952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral cortex hyperthyroidism of newborn mct8-deficient mice transiently suppressed by lat2 inactivation.
    Núñez B; Martínez de Mena R; Obregon MJ; Font-Llitjós M; Nunes V; Palacín M; Dumitrescu AM; Morte B; Bernal J
    PLoS One; 2014; 9(5):e96915. PubMed ID: 24819605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in thyroid status during perinatal development of MCT8-deficient male mice.
    Ferrara AM; Liao XH; Gil-Ibáñez P; Marcinkowski T; Bernal J; Weiss RE; Dumitrescu AM; Refetoff S
    Endocrinology; 2013 Jul; 154(7):2533-41. PubMed ID: 23696569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B; Gil-Ibañez P; Heuer H; Bernal J
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [No Abstract]   [Full Text] [Related]  

  • 6. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
    Mayerl S; Müller J; Bauer R; Richert S; Kassmann CM; Darras VM; Buder K; Boelen A; Visser TJ; Heuer H
    J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
    Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression.
    Wilpert NM; Krueger M; Opitz R; Sebinger D; Paisdzior S; Mages B; Schulz A; Spranger J; Wirth EK; Stachelscheid H; Mergenthaler P; Vajkoczy P; Krude H; Kühnen P; Bechmann I; Biebermann H
    Thyroid; 2020 Sep; 30(9):1366-1383. PubMed ID: 32143555
    [No Abstract]   [Full Text] [Related]  

  • 10. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.
    Liao XH; Avalos P; Shelest O; Ofan R; Shilo M; Bresee C; Likhite S; Vit JP; Heuer H; Kaspar B; Meyer K; Dumitrescu AM; Refetoff S; Svendsen CN; Vatine GD
    Thyroid; 2022 Jul; 32(7):849-859. PubMed ID: 35350867
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
    Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ
    Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
    Kersseboom S; Horn S; Visser WE; Chen J; Friesema EC; Vaurs-Barrière C; Peeters RP; Heuer H; Visser TJ
    Mol Endocrinol; 2014 Dec; 28(12):1961-70. PubMed ID: 25389909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zebrafish as a model for monocarboxyl transporter 8-deficiency.
    Vatine GD; Zada D; Lerer-Goldshtein T; Tovin A; Malkinson G; Yaniv K; Appelbaum L
    J Biol Chem; 2013 Jan; 288(1):169-80. PubMed ID: 23161551
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Groeneweg S; Kersseboom S; van den Berge A; Dolcetta-Capuzzo A; van Geest FS; van Heerebeek REA; Arjona FJ; Meima ME; Peeters RP; Visser WE; Visser TJ
    Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal Treatment of Thyroid Hormone Cell Membrane Transport Defect Caused by
    Refetoff S; Pappa T; Williams MK; Matheus MG; Liao XH; Hansen K; Nicol L; Pierce M; Blasco PA; Wiebers Jensen M; Bernal J; Weiss RE; Dumitrescu AM; LaFranchi S
    Thyroid; 2021 May; 31(5):713-720. PubMed ID: 32746752
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome.
    Maity-Kumar G; Ständer L; DeAngelis M; Lee S; Molenaar A; Becker L; Garrett L; Amerie OV; Hoelter SM; Wurst W; Fuchs H; Feuchtinger A; Gailus-Durner V; Garcia-Caceres C; Othman AE; Brockmann C; Schöffling VI; Beiser K; Krude H; Mroz PA; Hofmann S; Tuckermann J; DiMarchi RD; Hrabe de Angelis M; Tschöp MH; Pfluger PT; Müller TD
    Mol Metab; 2022 Dec; 66():101616. PubMed ID: 36270613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
    Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S
    JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of action of exogenously administered T3 on the fetal rat brain despite expression of the monocarboxylate transporter 8.
    Grijota-Martínez C; Díez D; Morreale de Escobar G; Bernal J; Morte B
    Endocrinology; 2011 Apr; 152(4):1713-21. PubMed ID: 21303950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation.
    Chan SY; Martín-Santos A; Loubière LS; González AM; Stieger B; Logan A; McCabe CJ; Franklyn JA; Kilby MD
    J Physiol; 2011 Jun; 589(Pt 11):2827-45. PubMed ID: 21486766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiological consequences of thyroid hormone transporter deficiencies: Insights from mouse models.
    Heuer H; Visser TJ
    Biochim Biophys Acta; 2013 Jul; 1830(7):3974-8. PubMed ID: 22543196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.